EFEKTIVITAS DAN KEAMANAN PEMBERIAN VAKSIN PADA PASIEN COVID-19
DOI:
https://doi.org/10.31004/jkt.v4i3.17009Keywords:
efektivitas, keamanan, pasien covid-19, vaksinAbstract
Covid-19 terjadi sekitar tahun 2019 ditemukan di Wuhan China pertama kali, Covid-19 merupakan coronavirus (CoVs) dimana penyakit yang menyerang pernafasan akut. Pemberian vaksinasi terhadap Covid-19 tidak hanya mencegah penyebaran virus tetapi juga mencegah terjadi komplikasi serius dari pandemi. Penelitian ini bertujuan untuk menganalisis efektivitas dan keamanan pemberian vaksin pada pasien covid-19. Strategi dalam mengumpulan article review kami mencari semua publikasi yang terkait dengan vaksin SARS-CoV-2 dari database berikut: EMBASE, Medline (melalui PubMed), dan Web of Science. Pencarian dalam pengambilan artikel “Covid-19” AND “Effectiveness” AND “Safiety” AND “Vaccine”. Hasil analisis menunjukkan bahwa Laki-laki memiliki efektivitas yang lebih tinggi perempuan yang menerima vaksin efektivitasnya 92,70 (95% CI 81-96,81) dan 87,84% (95% CI 75,78-9388). Usia 16-55 tahun 88,89% (95% CI 75,45-94,87) dan usia > 55 tahun 87,62% (95% CI 76,83-92,54). Berdasarkan etnis kulit hitam 95,37% (95% CI 47,92-100) dan putih 89,81% (95% CI 73,08-96,15). Efek samping penggunaan vaksin sering terjadi setelah pemberian vaksin dosis kedua. Efek samping yang umum terjadi di seluruh vaksin adalah kemerahan, nyeri bagian suntik, demam, kemerahan, menggigil, gatal. Vaksin terbukti memiliki efektivitas dalam menurunkan kejadian infeksi Covid-19, menurunkan gejala Covid-19, menurunkan angka kejadian masuk rumah sakit dan kematian. Efektivitas seluruh vaksin meningkat setelah pemberian dosis kedua dibandingkan dosis pertama hal ini juga setara dengan efek samping yang biasa muncul penggunaan vaksin setelah dosis kedua.References
Abbasi-oshaghi, E., Mirzaei, F., Farahani, F., & Khodadadi, I. (2020). Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information. International Journal of Surgery, January.
Aggarwal, A., Mehta, S., Gupta, D., Sheikh, S., Pallagatti, S., Singh, R., & Singla, I. (2012). Clinical & immunological erythematosus patients characteristics in systemic lupus Maryam. Journal of dental education, 76(11), 1532–1539. https://doi.org/10.4103/ijmr.IJMR
Amawi, H., Abu Deiab, G. I., A Aljabali, A. A., Dua, K., & Tambuwala, M. M. (2020). COVID-19 pandemic: An overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Therapeutic Delivery, 11(4), 245–268. https://doi.org/10.4155/tde-2020-0035
Cai, C., Peng, Y., Shen, E., Huang, Q., Chen, Y., Liu, P., Guo, C., Feng, Z., Gao, L., Zhang, X., Gao, Y., Liu, Y., Han, Y., Zeng, S., & Shen, H. (2021). A comprehensive analysis of the efficacy and safety of COVID-19 vaccines. Molecular Therapy, 29(9), 2794–2805. https://doi.org/10.1016/j.ymthe.2021.08.001
Chen, M., Yuan, Y., Zhou, Y., Deng, Z., Zhao, J., Feng, F., Zou, H., & Sun, C. (2021). Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials. Infectious Diseases of Poverty, 10(1), 1–12. https://doi.org/10.1186/s40249-021-00878-5
Dhama Kuldeep. (2020). Update on COVID-19, 10-2020. Clinical Microbiology Reviews, 33(4), 1–48.
Dighriri, I. M., Alhusayni, K. M., Mobarki, A. Y., Aljerary, I. S., Alqurashi, K. A., Aljuaid, F. A., Alamri, K. A., Mutwalli, A. A., Maashi, N. A., Aljohani, A. M., Alqarni, A. M., Alfaqih, A. E., Moazam, S. M., Almutairi, M. N., & Almutairi, A. N. (2022). Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) Side Effects: A Systematic Review. Cureus, 14(3), e23526. https://doi.org/10.7759/cureus.23526
Fan, Y., Chan, K. H., & Hung, I. F. N. (2021). Safety and efficacy of COVID-19 vaccines: A systematic review and meta-analysis of different vaccines at phase 3. Vaccines, 9(9), 1–15. https://doi.org/10.3390/vaccines9090989
Feikin, D. R., Higdon, M. M., Abu-Raddad, L. J., Andrews, N., Araos, R., Goldberg, Y., Groome, M. J., Huppert, A., O’Brien, K. L., Smith, P. G., Wilder-Smith, A., Zeger, S., Deloria Knoll, M., & Patel, M. K. (2022). Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. The Lancet, 399(10328), 924–944. https://doi.org/10.1016/S0140-6736(22)00152-0
Grant, M. C., Geoghegan, L., Arbyn, M., Mohammed, Z., McGuinness, L., Clarke, E. L., & Wade, R. G. (2020). The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS ONE, 15(6), e0234765. https://doi.org/10.1371/journal.pone.0234765
Januszek, S. M., Faryniak-Zuzak, A., Barna?, E., ?ozi?ski, T., Góra, T., Siwiec, N., Szczerba, P., Januszek, R., & Kluz, T. (2021). The approach of pregnant women to vaccination based on a covid-19 systematic review. Medicina (Lithuania), 57(9), 1–11. https://doi.org/10.3390/medicina57090977
Katoto, P. D. M. C., Brand, A. S., Byamungu, L. N., Tamuzi, J. L., Mahwire, T. C., Kitenge, M. K., Wiysonge, C. S., & Gray, G. (2022). Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis. Human Vaccines and Immunotherapeutics, 18(6), e2144039-1-e2144039-17. https://doi.org/10.1080/21645515.2022.2144039
Kaur, R. J., Dutta, S., Bhardwaj, P., Charan, J., Dhingra, S., Mitra, P., Singh, K., Yadav, D., Sharma, P., & Misra, S. (2021). Adverse Events Reported From COVID-19 Vaccine Trials: A Systematic Review. Indian Journal of Clinical Biochemistry, 36(4), 427–439. https://doi.org/10.1007/s12291-021-00968-z
Korang, S. K., von Rohden, E., Veroniki, A. A., Ong, G., Ngalamika, O., Siddiqui, F., Juul, S., Nielsen, E. E., Feinberg, J. B., Petersen, J. J., Legart, C., Kokogho, A., Maagaard, M., Klingenberg, S., Thabane, L., Bardach, A., Ciapponi, A., Thomsen, A. R., Jakobsen, J. C., & Gluud, C. (2022). Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials. PLoS ONE, 17(1), 1–23. https://doi.org/10.1371/journal.pone.0260733
Liu, Q., Qin, C., Liu, M., & Liu, J. (2021). Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis. Infectious Diseases of Poverty, 10(1), 1–15. https://doi.org/10.1186/s40249-021-00915-3
Maurya, S. K., Bhattacharya, A., Shukla, P., & Mishra, R. (2022). Insights on Epidemiology, Pathogenesis, Diagnosis and Possible Treatment of COVID-19 Infection. Proceedings of the National Academy of Sciences India Section B - Biological Sciences, 92(3), 485–493. https://doi.org/10.1007/s40011-021-01319-x
Melenotte, C., Silvin, A., Goubet, A. G., Lahmar, I., Dubuisson, A., Zumla, A., Raoult, D., Merad, M., Gachot, B., Hénon, C., Solary, E., Fontenay, M., André, F., Maeurer, M., Ippolito, G., Piacentini, M., Wang, F. S., Ginhoux, F., Marabelle, A., … Zitvogel, L. (2020). Immune responses during COVID-19 infection. OncoImmunology, 9(1), 1–23. https://doi.org/10.1080/2162402X.2020.1807836
Ning, Z. (n.d.). E cacy and safety of COVID- inactivated vaccine?: A.
PDPI, PERKI, PAPDI, PERDATIN, & IDAI. (2020). Pedoman tatalaksana COVID-19 Edisi 1 April 2020. In Pedoman Tatalaksana COVID-19.
Petrelli, F., Luciani, A., Borgonovo, K., Ghilardi, M., Parati, M. C., Petrò, D., Lonati, V., Pesenti, A., & Cabiddu, M. (2022). Third dose of SARS-CoV-2 vaccine: A systematic review of 30 published studies. Journal of Medical Virology, 94(6), 2837–2844. https://doi.org/10.1002/jmv.27644
Pormohammad, A., Zarei, M., Ghorbani, S., Mohammadi, M., Razizadeh, M. H., Turner, D. L., & Turner, R. J. (2021). Efficacy and safety of covid-19 vaccines: A systematic review and meta-analysis of randomized clinical trials. Vaccines, 9(5), 1–21. https://doi.org/10.3390/vaccines9050467
Sharif, N., Alzahrani, K. J., Ahmed, S. N., & Dey, S. K. (2021). Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis. Frontiers in Immunology, 12(10), 1–11. https://doi.org/10.3389/fimmu.2021.714170
The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information. (2020). January.
Wang, J., Tong, Y., Li, D., Li, J., & Li, Y. (2021). The Impact of Age Difference on the Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis. Frontiers in Immunology, 12(12), 1–8. https://doi.org/10.3389/fimmu.2021.758294
Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020). Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA - Journal of the American Medical Association, 324(8), 782–793. https://doi.org/10.1001/jama.2020.12839
Yuki, K., Fujiogi, M., & Koutsogiannaki, S. (2020). Covid-19 pathophysiology. January.
Zhang, L., Jiang, L., Tian, T., Li, W., Pan, Y., & Wang, Y. (2022). Efficacy and Safety of COVID-19 Vaccination in Older Adults: A Systematic Review and Meta-Analysis. Vaccines, 11(1), 33. https://doi.org/10.3390/vaccines11010033
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Festy Kharisma, Fauna Herawati
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
